Govt hospitals drug samples fail Delhi’s Drug Control Department test

Published On 2015-09-02 04:24 GMT   |   Update On 2015-09-02 04:24 GMT

Drug samples collected from 10 govt hospitals in Delhi including Sanjay Gandhi Hospital, Central Medical Store MCD Building (Civil Lines), Safdarjung Hospital, AIIMS, Shri Dada Dev Matri Avum Shishu Chikitsalaya (Dabri), Lok Nayak Hospital, GTB Hospital, Deen Dayal Upadhyay Hospital, Acharya Shree Bhikshu Hospital and Rao Tula Ram Memorial Hospital, have failed the Delhi’s Drug...

Login or Register to read the full article
Drug samples collected from 10 govt hospitals in Delhi including Sanjay Gandhi Hospital, Central Medical Store MCD Building (Civil Lines), Safdarjung Hospital, AIIMS, Shri Dada Dev Matri Avum Shishu Chikitsalaya (Dabri), Lok Nayak Hospital, GTB Hospital, Deen Dayal Upadhyay Hospital, Acharya Shree Bhikshu Hospital and Rao Tula Ram Memorial Hospital, have failed the Delhi’s Drug Control Department test.

As per the information given by the department, anti-inflammatory drug Regunac and painkillers Diclofenac and Aspirin procured from Sanjay Gandhi Memorial Hospital in Mongolpuri, and Atenolol, to treat high blood pressure, and Aspirin from AIIMS failed to clear the test.

Anti-parasitic drug Albendazole procured from Lok Nayak Hospital and samples of cotton bandage roll from Safdarjung, GTB and Acharya Shree Bhikshu hospitals also failed the test.

Sixteen samples of drugs procured from ten government hospitals in the national capital did not pass the test of Delhi's Drug Control Department between April 2010 and March 2015, according to an RTI reply.

This information was given by the Drug Control Department of Delhi in reply to an Right To Information (RTI) query by activist Rajhans Bansal.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News